I am senior reporter for Scrip Intelligence, all views expressed are my own.

Read Full Bio →


Francesca covers a range of policy and regulatory developments in Europe, with a focus on pricing and reimbursement and market access. In her role at Scrip she has also covered key emerging markets in Latin America, concentrating on Brazil, Mexico and Argentina.

Search Tweets

Twitter Feed

@ScripFrancesca — 567 followers, 105 tweets

Brazil's IP system could get more challenging for pharma companies  http://bit.ly/2pFHiyn 
RT @scripanjug: Minister Ananth Kumar says India will persuade docs to follow generic prescription rule and also propagate it
RT @PharmaScrip: The #ScripAwards is free to enter and open to any research-based #pharmaceutical or #biotech company.…
Advances in digital healthcare and a new law could make Brazil a better place to do clinical research  http://bit.ly/2r3hjCk 
Show More